These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 21515087

  • 21. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G, Brücke T, Odin P, Brooks DJ, Kolbe H, Gielow P, Harke H, Knoop BO, Dengler R, Knapp WH.
    Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
    [Abstract] [Full Text] [Related]

  • 22. Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease.
    Ravina B, Marek K, Eberly S, Oakes D, Kurlan R, Ascherio A, Beal F, Beck J, Flagg E, Galpern WR, Harman J, Lang AE, Schwarzschild M, Tanner C, Shoulson I.
    Mov Disord; 2012 Sep 15; 27(11):1392-7. PubMed ID: 22976926
    [Abstract] [Full Text] [Related]

  • 23. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.
    Geng Y, Shi GH, Jiang Y, Xu LX, Hu XY, Shao YQ.
    J Zhejiang Univ Sci B; 2005 Jan 15; 6(1):22-7. PubMed ID: 15593387
    [Abstract] [Full Text] [Related]

  • 24. Measuring the progression of idiopathic Parkinson's disease with [123I] beta-CIT SPECT.
    Staffen W, Mair A, Unterrainer J, Trinka E, Ladurner G.
    J Neural Transm (Vienna); 2000 Jan 15; 107(5):543-52. PubMed ID: 11072750
    [Abstract] [Full Text] [Related]

  • 25. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C, Frosini D, Volterrani D, De Feo P, Unti E, Nicoletti V, Kiferle L, Bonuccelli U, Ceravolo R.
    Eur J Neurol; 2010 Apr 15; 17(4):626-30. PubMed ID: 20050904
    [Abstract] [Full Text] [Related]

  • 26. Do non-motor symptoms in Parkinson's disease differ from essential tremor before initial diagnosis? A clinical and scintigraphic study.
    Giorelli M, Bagnoli J, Consiglio L, Lopane M, Zimatore GB, Zizza D, Difazio P.
    Parkinsonism Relat Disord; 2014 Jan 15; 20(1):17-21. PubMed ID: 24080307
    [Abstract] [Full Text] [Related]

  • 27. Genome-wide variant by serum urate interaction in Parkinson's disease.
    Nazeri A, Roostaei T, Sadaghiani S, Chakravarty MM, Eberly S, Lang AE, Voineskos AN.
    Ann Neurol; 2015 Nov 15; 78(5):731-41. PubMed ID: 26284320
    [Abstract] [Full Text] [Related]

  • 28. Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images.
    Rahmim A, Huang P, Shenkov N, Fotouhi S, Davoodi-Bojd E, Lu L, Mari Z, Soltanian-Zadeh H, Sossi V.
    Neuroimage Clin; 2017 Nov 15; 16():539-544. PubMed ID: 29868437
    [Abstract] [Full Text] [Related]

  • 29. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M, Djaldetti R, Melamed E, Sadeh M, Lampl Y.
    J Nucl Med; 2004 Oct 15; 45(10):1688-93. PubMed ID: 15471834
    [Abstract] [Full Text] [Related]

  • 30. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G, Vitale C, Picillo M, Cuoco S, Moccia M, Pezzella D, Erro R, Longo K, Vicidomini C, Pellecchia MT, Amboni M, Brunetti A, Salvatore M, Barone P, Pappatà S.
    Parkinsonism Relat Disord; 2015 May 15; 21(5):489-93. PubMed ID: 25753457
    [Abstract] [Full Text] [Related]

  • 31. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
    Spiegel J, Möllers MO, Jost WH, Fuss G, Samnick S, Dillmann U, Becker G, Kirsch CM.
    Mov Disord; 2005 May 15; 20(5):552-61. PubMed ID: 15645531
    [Abstract] [Full Text] [Related]

  • 32. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Ishikawa T, Dhawan V, Kazumata K, Chaly T, Mandel F, Neumeyer J, Margouleff C, Babchyck B, Zanzi I, Eidelberg D.
    J Nucl Med; 1996 Nov 15; 37(11):1760-5. PubMed ID: 8917170
    [Abstract] [Full Text] [Related]

  • 33. Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease.
    Ransmayr G, Seppi K, Donnemiller E, Luginger E, Marksteiner J, Riccabona G, Poewe W, Wenning GK.
    Eur J Nucl Med; 2001 Oct 15; 28(10):1523-8. PubMed ID: 11685496
    [Abstract] [Full Text] [Related]

  • 34. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP, Marek K, Sheff K, Baldwin RM, Zoghbi S, Zea-Ponce Y, Charney DS, van Dyck CH, Hoffer PB, Innis RB.
    J Nucl Med; 1997 Sep 15; 38(9):1453-9. PubMed ID: 9293807
    [Abstract] [Full Text] [Related]

  • 35. Levodopa and the progression of Parkinson's disease.
    Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K, Parkinson Study Group.
    N Engl J Med; 2004 Dec 09; 351(24):2498-508. PubMed ID: 15590952
    [Abstract] [Full Text] [Related]

  • 36. Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
    Ichise M, Kim YJ, Erami SS, Ballinger JR, Vines D, Tanaka F, Lang AE.
    J Nucl Med; 1999 Apr 09; 40(4):530-8. PubMed ID: 10210210
    [Abstract] [Full Text] [Related]

  • 37. [123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.
    Gerschlager W, Bencsits G, Pirker W, Bloem BR, Asenbaum S, Prayer D, Zijlmans JC, Hoffmann M, Brücke T.
    Mov Disord; 2002 May 09; 17(3):518-23. PubMed ID: 12112200
    [Abstract] [Full Text] [Related]

  • 38. Baseline [(123) I]FP-CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson's disease.
    Nissen T, Malek N, Grosset KA, Newman EJ, Patterson J, Hadley D, Grosset DG.
    Acta Neurol Scand; 2014 Mar 09; 129(3):204-8. PubMed ID: 23962145
    [Abstract] [Full Text] [Related]

  • 39. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, Janssen AG, Stoof JC, van Royen EA.
    J Nucl Med; 1998 Nov 09; 39(11):1879-84. PubMed ID: 9829575
    [Abstract] [Full Text] [Related]

  • 40. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP.
    Neurology; 2005 Nov 08; 65(9):1436-41. PubMed ID: 16275832
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.